A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a single-center, randomized, double-blind, placebo-controlled, escalating single-dose and multiple-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HEC88473 injection in healthy subjects, obese subjects and subjects with type 2 diabetes mellitus (T2DM).
Epistemonikos ID: a8ef7080da4e523ffbf2e594bd81e64a701b93e1
First added on: May 15, 2024